Terns Pharmaceuticals, Inc.

TERN - Company ID 0001831363

Market cap$6.12 B

Rank#1269

Filings430

Terns Pharmaceuticals, Inc. has filed 430 public company documents between 2020 and 2026. The most frequent type is insider trade (139 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.

Continue researchTERN overview$6.12 BMarket cap, financials, charts, and latest company context.

Continue researchMarket cap historyRank #1269See the market value trend behind the filing history.

Continue researchRevenue trendAnnual historyMove from documents into filing-backed operating results.

Continue researchCompare with LLYPeer viewPut TERN beside LLY across market cap, revenue, income, and filings.

Browse latest filings across all companies →Follow TERN via RSS

Similar companies to research next

LLYEli Lilly and Company

Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.

Type	Filing	Filed	Period covered	Open
10-Q	Quarterly report	2y ago2023-11-14	2023-09-30	View filing
10-Q	Quarterly report	2y ago2023-08-08	2023-06-30	View filing
10-Q	Quarterly report	3y ago2023-05-15	2023-03-31	View filing

Terns Pharmaceuticals, Inc.

Similar companies to research next

Year